Persistence of von Willebrand factor abnormalities in patients with myeloproliferative disease in spite of use of antiproteolytic mixture as anticoagulant.
Alessandra
C
C
Fabrizio
F
F
Immacolata
C
C
Antonio
G
G
D000925:Anticoagulants; D006801:Humans; D009196:Myeloproliferative Disorders / Q000097:blood*; D011480:Protease Inhibitors; D014842:von Willebrand Diseases / Q000097:blood*
D000925:Anticoagulants; D011480:Protease Inhibitors